The Changes of Psychometric Profiles after Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: To investigate the relationship of somatization and depression with the degree of lower urinary tract symptoms suggestive of benign prostate hyperplasia (LUTS/BPH) and changes in psychometric profiles including somatization and depression after treatment of LUTS/BPH. Methods: Subjects were evaluated at baseline and at week 12 following routine treatment for LUTS/BPH using the International Prostate Symptom Score (IPSS) to measure the severity of LUTS/BPH, the Overactive Bladder Symptom Score (OABSS) to measure the severity of OAB, the Patient Health Questionnaire-9 (PHQ-9) to assess depression, and the Patient Health Questionnaire-15 (PHQ-15) to evaluate somatization. The correlation of somatization and depression with the degree of LUTS/BPH symptoms at baseline and changes in somatization and depression after LUTS/BPH treatment were assessed using relevant statistical analyses. Results: One hundred and twenty patients agreed to participate in this study, and 101 (84.2%) completed the 12-week trial and responded to the study questionnaires. At baseline, total IPSS score was correlated with PHQ-9 (r=0.475, p=0.005) and PHQ-15 (r=0.596, p＜0.001) scores. The results after the 12-week treatment clearly show significant improvement in both PHQ-9 (p ＜0.001) and PHQ-15 (p=0.019) scores, and the PHQ-9 (r=0.509, p=0.048) and PHQ-15 (r=0.541, p=0.016) scores were positively correlated with total IPSS. Conclusion: Our preliminary results indicated that severity of LUTS is correlated with severity of somatization and depression. Further, the improvement of LUTS after treatment may have positive impacts on somatization and depression.
Abstract
Objective: To investigate the relationship of somatization and depression with the degree of lower urinary tract symptoms suggestive of benign prostate hyperplasia (LUTS/BPH) and changes in psychometric profiles including somatization and depression after treatment of LUTS/BPH. Methods: Subjects were evaluated at baseline and at week 12 following routine treatment for LUTS/BPH using the International Prostate Symptom Score (IPSS) to measure the severity of LUTS/BPH, the Overactive Bladder Symptom Score (OABSS) to measure the severity of OAB, the Patient Health Questionnaire-9 (PHQ-9) to assess depression, and the Patient Health Questionnaire-15 (PHQ-15) to evaluate somatization. The correlation of somatization and depression with the degree of LUTS/BPH symptoms at baseline and changes in somatization and depression after LUTS/BPH treatment were assessed using relevant statistical analyses. Results: One hundred and twenty patients agreed to participate in this study, and 101 (84.2%) completed the 12-week trial and responded to the study questionnaires. At baseline, total IPSS score was correlated with PHQ-9 (r=0.475, p=0.005) and PHQ-15 (r=0.596, p＜0.001) scores. The results after the 12-week treatment clearly show significant improvement in both PHQ-9 (p ＜0.001) and PHQ-15 (p=0.019) scores, and the PHQ-9 (r=0.509, p=0.048) and PHQ-15 (r=0.541, p=0.016) scores were positively correlated with total IPSS. Conclusion: Our preliminary results indicated that severity of LUTS is correlated with severity of somatization and depression. Further, the improvement of LUTS after treatment may have positive impacts on somatization and depression.
참고문헌 (30)
- Irwin DE., "Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study", Eur Urol, 50, pp.1306~1314 (2006)
- Coyne KS., "The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS", BJU Int, 103(Suppl 3), pp.4~11 (2009)
- Robertson C., "The impact of lower urinary tract symptoms and comorbidities on quality of life : the BACH and UREPIK studies", BJU Int, 99, pp.347~354 (2007)
- Wong SY., "Lower urinary tract symptoms and depressive symptoms in elderly men", J Affect Disord, 96, pp.83~88 (2006)
- 유은상, "The Impact of Overactive Bladder on Health-Related Quality of Life, Sexual Life and Psychological Health in Korea", International Neurourology Journal, 15(3), pp.143~151 (2011), 대한배뇨장애요실금학회
- Breyer BN., "The association of depression, anxiety and nocturia : a systematic review", J Urol, 190, pp.953~957 (2013)
- Felde G., "Anxiety and depression associated with incontinence in middle-aged women : a large Norwegian cross-sectional study", Int Urogynecol J, 23, pp.299~306 (2012)
- Coyne KS., "Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States", Eur Urol, 61, pp.88~95 (2012)
- Lai HH., "Polysymptomatic, polysyndromic presentation of patients with urological chronic pelvic pain syndrome", J Urol, 187, pp.2106~2112 (2012)
- Han C., "Validation of the Patient Health Questionnaire-9 Korean version in the elderly population : the Ansan Geriatric study", Compr Psychiatry, 49, pp.218~223 (2008)
- Kroenke K., "The PHQ-9 : validity of a brief depression severity measure", J Gen Intern Med, 16, pp.606~613 (2001)
- Han C., "Psychometric properties of the Patient Health Questionnaire-15(PHQ-15)for measuring the somatic symptoms of psychiatric outpatients", Psychosomatics, 50, pp.580~585 (2009)
- Kroenke K., "The PHQ-15 : validity of a new measure for evaluating the severity of somatic symptoms", Psychosom Med, 64, pp.258~266 (2002)
- Barry MJ., "The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association", J Urol, 148, pp.1549~1557 (1992)
- Homma Y., "Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score", Urology, 68, pp.318~323 (2006)
- Löwe B., "Monitoring depression treatment outcomes with the patient health questionnaire-9", Med Care, 42, pp.1194~1201 (2004)
- Han C., "Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder : a 12-week prospective, open-label, randomized, parallel-group trial", Clin Drug Investig, 28, pp.251~261 (2008)
- Moore M., "Depression management in primary care: an observational study of management changes related to PHQ-9 score for depression monitoring", Br J Gen Pract, 62, pp.e451~e457 (2012)
- Interian A., "Somatic complaints in primary care : further examining the validity of the Patient Health Questionnaire(PHQ-15)", Psychosomatics, 47, pp.392~398 (2006)
- Chung RY., "Lower urinary tract symptoms(LUTS)as a risk factor for depressive symptoms in elderly men : results from a large prospective study in Southern Chinese men. PLoS One, 8", e76017 (2013)
- Lipowski ZJ., "Somatization : the concept and its clinical application", Am J Psychiatry, 145, pp.1358~1368 (1988)
- Stone J., "Functional symptoms in neurology: management", J Neurol Neurosurg Psychiatry, 76(Suppl 1), pp.i13~i21 (2005)
- Roehrborn CG., "The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia : 4-year results from the CombAT study", Eur Urol, 57, pp.123~131 (2010)
- McConnell JD., "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia", N Engl J Med, 349, pp.2387~2398 (2003)
- Quek KF., "Effect of treating lower urinary tract symptoms on anxiety, depression and psychiatric morbidity : a one-year study", Int J Urol, 11, pp.848~855 (2004)
- Quek KF., "The psychological effects of treatments for lower urinary tract symptoms", BJU Int, 86, pp.630~633 (2000)
- Innerkofler PC., "Improvement of quality of life, anxiety and depression after surgery in patients with stress urinary incontinence : results of a longitudinal short-term follow-up", Health Qual Life Outcomes, 6, pp.72~ (2008)
- Nicolau J., "Treatment of depression in type 2 diabetic patients : effects on depressive symptoms, quality of life and metabolic control", Diabetes Res Clin Pract, 101, pp.148~152 (2013)
- Serafini G., "The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional study", Prim Care Companion J Clin Psychiatry, 12 (2010)
- Strine TW., "The associations between depression, health-related quality of life, social support, life satisfaction, and disability in community-dwelling US adults", J Nerv Ment Dis, 197, pp.61~64 (2009)